Detalhe da pesquisa
1.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34936697
2.
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Br J Haematol
; 201(2): 256-266, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36740991
3.
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
Ann Hematol
; 102(7): 1811-1823, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37058153
4.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood
; 135(16): 1396-1405, 2020 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31978225
5.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30184451
6.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31702836
7.
Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy.
Eur Radiol
; 30(8): 4623-4632, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32248365
8.
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large Bcell lymphoma: results of a multicentric prospective cohort study.
Ann Hematol
; 103(1): 369, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37880485
9.
Bendamustine and rituximab in elderly patients with low-tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study.
Br J Haematol
; 183(1): 76-86, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30117149
10.
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.
Eur J Nucl Med Mol Imaging
; 45(5): 699-711, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29214417
11.
Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.
Eur J Nucl Med Mol Imaging
; 45(4): 675, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29288275
12.
Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.
Eur J Nucl Med Mol Imaging
; 45(6): 941-950, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29279943
13.
Upfront consolidation combining yttrium-90 ibritumomab tiuxetan and high-dose therapy with stem cell transplantation in poor-risk patients with diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
; 20(12): 1905-11, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25072780
14.
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.
Lancet Oncol
; 14(6): 525-33, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23578722
15.
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood Adv
; 8(2): 296-308, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37874913
16.
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Lancet
; 378(9806): 1858-67, 2011 Nov 26.
Artigo
Inglês
| MEDLINE | ID: mdl-22118442
17.
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).
Blood
; 115(1): 32-7, 2010 Jan 07.
Artigo
Inglês
| MEDLINE | ID: mdl-19884643
18.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 12(5): 460-8, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21482186
19.
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.
Cancers (Basel)
; 14(7)2022 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35406532
20.
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial.
Blood Adv
; 6(24): 6169-6179, 2022 12 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35737565